Tech Center 1600 • Art Units: 1631 1633
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17913540 | Compositions and Methods for Treatment | Non-Final OA | The Regents of the University of California |
| 18248193 | PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18010773 | TARGETING THE HUMAN CCR5 LOCUS AS A SAFE HARBOR FOR THE EXPRESSION OF THERAPEUTIC PROTEINS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18449100 | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD | Non-Final OA | FUJIFILM Cellular Dynamics, Inc. |
| 18309370 | CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE | Final Rejection | The Trustees of the University of Pennsylvania |
| 17580219 | INCREASING GENOME STABILITY AND REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | Non-Final OA | DUKE UNIVERSITY |
| 18170671 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME | Non-Final OA | NATIONAL YANG MING CHIAO TUNG UNIVERSITY |
| 18517402 | METHOD FOR PREPARING BROWN ADIPOCYTE | Non-Final OA | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
| 17911018 | COMPOSITION FOR INDUCING APOPTOSIS OF CELLS HAVING GENOMIC SEQUENCE VARIATION AND METHOD FOR INDUCING APOPTOSIS OF CELLS BY USING COMPOSITION | Non-Final OA | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) |
| 17759832 | MICRORNA-7 COMPOSITIONS FOR PROMOTING FUNCTIONAL RECOVERY FOLLOWING SPINAL CORD INJURY AND METHODS OF USE THEREOF | Final Rejection | Rutgers, The State University of New Jersey |
| 17782924 | A HEMOSTATIC AGENT AND USES THEREOF | Final Rejection | ROYAL COLLEGE OF SURGEONS IN IRELAND |
| 18424395 | BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS | Final Rejection | City of Hope |
| 17430382 | MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY | Non-Final OA | Editas Medicine, Inc. |
| 17799239 | BCMA-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS AND METHODS AND USES THEREOF | Non-Final OA | Juno Therapeutics, Inc. |
| 17767687 | Chimeric Cytokine Receptors | Non-Final OA | UVic Industry Partnerships Inc. |
| 18235476 | VISIBLE LIGHT POLYMERIZATION OF POLYETHYLENE GLYCOL (PEG) HYDROGELS | Non-Final OA | STEM PHARM, INCORPORATED |
| 18359916 | NON-INVASIVE METHOD FOR GENERATING HUMAN THREE-DIMENSIONAL AND TWO- DIMENSIONAL NASOPHARYNGEAL ORGANOIDS | Non-Final OA | Centre for Immunology & Infection Limited |
| 15780542 | SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR CLINICAL USE | Final Rejection | SPARK THERAPEUTICS, INC. |
| 18300852 | NATURAL KILLER CELL HAVING CONTROLLED ONCOLOGY-RELEATED GENE EXPRESSION, AND USE THEREOF | Non-Final OA | CHA BIOLAB CO., LTD. |
| 18043501 | CELL PREPARATION FOR USE IN SUPPRESSING MUSCLE MASS LOSS | Non-Final OA | HUMAN LIFE CORD JAPAN INC. |
| 17907318 | METHOD FOR OBTAINING ENDOMETRIAL MESENCHYMAL STEM CELLS FROM HUMAN MENSTRUAL BLOOD | Non-Final OA | SHANGHAI WOLWO STEM CELL TECHNOLOGY CO., LTD. |
| 17822767 | METHODS FOR EX VIVO ENRICHMENT AND EXPANSION OF TUMOR REACTIVE T CELLS AND RELATED COMPOSITIONS THEREOF | Final Rejection | TURNSTONE BIOLOGICS CORP. |
| 17258533 | USE OF IL-12 TO ALTER EPIGENETIC EFFECTOR PROGRAMS IN CD8 T CELLS | Non-Final OA | St. Jude Children's Research Hospital |
| 15779869 | METHOD FOR PRODUCING MESENCHYMAL STEM CELLS | Final Rejection | TAKARA BIO INC. |
| 17620047 | ROTAVIRUS MRNA VACCINE | Final Rejection | CureVac AG |
| 17632938 | COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF AGENTS | Non-Final OA | Moderna TX, Inc. |
| 17603935 | MONITORING GENE THERAPY | Non-Final OA | LogicBio Therapeutics, Inc. |
| 17288041 | Porcine Scaffolds and Methods of Preparation | Non-Final OA | Convatec Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy